We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleTBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer.AuthorsCarey, Lisa A.; Rugo, Hope S.; Marcom, P. Kelly; Mayer, Erica L.; Esteva, Francisco J.; Ma, Cynthia X.; Liu, Minetta C.; Storniolo, Anna Maria; Rimawi, Mothaffar F.; Forero-Torres, Andres; Wolff, Antonio C.; Hobday, Timothy J.; Ivanova, Anastasia; Wing-Keung Chiu; Ferraro, Madlyn; Burrows, Emily; Bernard, Philip S.; Hoadley, Katherine A.; Perou, Charles M.; Winer, Eric P.PublicationJournal of Clinical Oncology, 2012, Vol 30, Issue 21, p2615ISSN0732-183xPublication typearticleDOI10.1200/JCO.2010.34.5579